Prospective assessment of the predictive value of the BRCA1 gene status in sarcoma patients treated with trabectedin: an updated analysis of the EORTC 62091 trial.
Italiano, Antoine
Prospective assessment of the predictive value of the BRCA1 gene status in sarcoma patients treated with trabectedin: an updated analysis of the EORTC 62091 trial. [electronic resource] - Cancer medicine 05 2018 - 1575-1577 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
2045-7634
10.1002/cam4.1403 doi
Female
Humans
Male
Antineoplastic Agents, Alkylating--therapeutic use
BRCA1 Protein--genetics
Genotype
Predictive Value of Tests
Prospective Studies
Sarcoma--drug therapy
Trabectedin--therapeutic use
Treatment Outcome
Prospective assessment of the predictive value of the BRCA1 gene status in sarcoma patients treated with trabectedin: an updated analysis of the EORTC 62091 trial. [electronic resource] - Cancer medicine 05 2018 - 1575-1577 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
2045-7634
10.1002/cam4.1403 doi
Female
Humans
Male
Antineoplastic Agents, Alkylating--therapeutic use
BRCA1 Protein--genetics
Genotype
Predictive Value of Tests
Prospective Studies
Sarcoma--drug therapy
Trabectedin--therapeutic use
Treatment Outcome